Cargando…
Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives
Drug-induced liver injury (DILI) is one among the common adverse drug reactions and the leading causes of drug development attritions, black box warnings, and post-marketing withdrawals. Despite having relatively low clinical incidence, its potentially severe adverse events should be considered in t...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002317/ https://www.ncbi.nlm.nih.gov/pubmed/32082163 http://dx.doi.org/10.3389/fphar.2019.01667 |